Affordable Access

Targeted HPMA copolymer-bound doxorubicin conjugates in the treatment of established tumors and induction of effective anti-tumor immunity

Publication Date
  • Hpma


Thus, treatment with B1 mAb-targeted conjugates is able to completely cured BCL 1 bearing mice and most importantly, break immunoescaping mechanisms of BCL1 cells

There are no comments yet on this publication. Be the first to share your thoughts.